| Product Code: ETC7347388 | Publication Date: Sep 2024 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In the Greece drug-device combination products market, the import trend experienced a decline from 2023 to 2024, with a growth rate of -6.42%. However, the compound annual growth rate (CAGR) for the period 2020-2024 stood at 3.59%. This negative momentum in imports could be attributed to shifting demand patterns or changes in market dynamics affecting trade flows.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Drug-Device Combination Products Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Drug-Device Combination Products Market Revenues & Volume, 2022 & 2032F |
3.3 Greece Drug-Device Combination Products Market - Industry Life Cycle |
3.4 Greece Drug-Device Combination Products Market - Porter's Five Forces |
3.5 Greece Drug-Device Combination Products Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Greece Drug-Device Combination Products Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Greece Drug-Device Combination Products Market Revenues & Volume Share, By End user, 2022 & 2032F |
4 Greece Drug-Device Combination Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Greece leading to higher demand for advanced treatment options. |
4.2.2 Growing aging population in Greece requiring more innovative drug-device combination products for healthcare management. |
4.2.3 Technological advancements in drug delivery systems driving the development of new and improved combination products. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of drug-device combination products leading to longer time to market. |
4.3.2 Limited reimbursement policies for these products affecting their adoption and affordability in the market. |
5 Greece Drug-Device Combination Products Market Trends |
6 Greece Drug-Device Combination Products Market, By Types |
6.1 Greece Drug-Device Combination Products Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Greece Drug-Device Combination Products Market Revenues & Volume, By Product, 2022-2032F |
6.1.3 Greece Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting stents, 2022-2032F |
6.1.4 Greece Drug-Device Combination Products Market Revenues & Volume, By Infusion pumps, 2022-2032F |
6.1.5 Greece Drug-Device Combination Products Market Revenues & Volume, By Photodynamic therapy, 2022-2032F |
6.1.6 Greece Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial wound dressings, 2022-2032F |
6.1.7 Greece Drug-Device Combination Products Market Revenues & Volume, By Prefilled syringes, 2022-2032F |
6.1.8 Greece Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting balloons, 2022-2032F |
6.1.9 Greece Drug-Device Combination Products Market Revenues & Volume, By Other, 2022-2032F |
6.1.10 Greece Drug-Device Combination Products Market Revenues & Volume, By Other, 2022-2032F |
6.2 Greece Drug-Device Combination Products Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Greece Drug-Device Combination Products Market Revenues & Volume, By Cardiovascular Disorders, 2022-2032F |
6.2.3 Greece Drug-Device Combination Products Market Revenues & Volume, By Diabetes, 2022-2032F |
6.2.4 Greece Drug-Device Combination Products Market Revenues & Volume, By Respiratory Problems, 2022-2032F |
6.2.5 Greece Drug-Device Combination Products Market Revenues & Volume, By Cancer Treatment, 2022-2032F |
6.2.6 Greece Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial Application, 2022-2032F |
6.2.7 Greece Drug-Device Combination Products Market Revenues & Volume, By Other, 2022-2032F |
6.3 Greece Drug-Device Combination Products Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 Greece Drug-Device Combination Products Market Revenues & Volume, By Hospital & clinic, 2022-2032F |
6.3.3 Greece Drug-Device Combination Products Market Revenues & Volume, By Ambulatory surgery center (asc), 2022-2032F |
6.3.4 Greece Drug-Device Combination Products Market Revenues & Volume, By Home care setting, 2022-2032F |
6.3.5 Greece Drug-Device Combination Products Market Revenues & Volume, By Other, 2022-2032F |
7 Greece Drug-Device Combination Products Market Import-Export Trade Statistics |
7.1 Greece Drug-Device Combination Products Market Export to Major Countries |
7.2 Greece Drug-Device Combination Products Market Imports from Major Countries |
8 Greece Drug-Device Combination Products Market Key Performance Indicators |
8.1 Rate of adoption of drug-device combination products by healthcare providers in Greece. |
8.2 Number of clinical trials and research studies conducted on new drug-device combination products in the market. |
8.3 Level of investment in research and development for innovative drug-device combination products in Greece. |
9 Greece Drug-Device Combination Products Market - Opportunity Assessment |
9.1 Greece Drug-Device Combination Products Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Greece Drug-Device Combination Products Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Greece Drug-Device Combination Products Market Opportunity Assessment, By End user, 2022 & 2032F |
10 Greece Drug-Device Combination Products Market - Competitive Landscape |
10.1 Greece Drug-Device Combination Products Market Revenue Share, By Companies, 2025 |
10.2 Greece Drug-Device Combination Products Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here